X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16007) 16007
Book Review (3860) 3860
Publication (1133) 1133
Book Chapter (204) 204
Book / eBook (163) 163
Conference Proceeding (93) 93
Newsletter (88) 88
Magazine Article (47) 47
Newspaper Article (42) 42
Dissertation (15) 15
Reference (4) 4
Trade Publication Article (3) 3
Data Set (2) 2
Government Document (1) 1
Paper (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12339) 12339
humans (9389) 9389
male (4586) 4586
animals (4431) 4431
female (4120) 4120
vitamin k - antagonists & inhibitors (2552) 2552
warfarin (2300) 2300
aged (2269) 2269
middle aged (2166) 2166
anticoagulants (1924) 1924
risk factors (1803) 1803
rats (1784) 1784
anticoagulants - therapeutic use (1754) 1754
vitamin d (1661) 1661
adult (1557) 1557
pharmacology & pharmacy (1464) 1464
vitamin k (1415) 1415
anticoagulants - adverse effects (1384) 1384
biochemistry & molecular biology (1351) 1351
atrial fibrillation (1338) 1338
mice (1303) 1303
research (1297) 1297
hematology (1287) 1287
anticoagulants - administration & dosage (1240) 1240
analysis (1169) 1169
administration, oral (1144) 1144
oxidative stress (1117) 1117
vitamins (1112) 1112
peripheral vascular disease (1096) 1096
health aspects (1077) 1077
care and treatment (1012) 1012
prevention (1010) 1010
stroke (1007) 1007
abridged index medicus (1006) 1006
aged, 80 and over (1006) 1006
risk (1001) 1001
medicine & public health (995) 995
cardiac & cardiovascular systems (970) 970
treatment outcome (897) 897
vitamin-e (855) 855
metabolism (854) 854
dabigatran (852) 852
endocrinology & metabolism (849) 849
therapy (847) 847
physiological aspects (843) 843
medicine, general & internal (835) 835
vitamin k antagonists (809) 809
anticoagulation (808) 808
hemorrhage - chemically induced (801) 801
cancer (794) 794
cell biology (784) 784
international normalized ratio (782) 782
thromboembolism (782) 782
atrial fibrillation - drug therapy (779) 779
dose-response relationship, drug (769) 769
proteins (741) 741
medicine (737) 737
rivaroxaban (732) 732
patients (727) 727
time factors (707) 707
management (699) 699
alfacalcidol (691) 691
oncology (688) 688
calcifediol (686) 686
atrial-fibrillation (658) 658
venous thromboembolism (654) 654
antioxidants (643) 643
vitamin-k antagonists (639) 639
article (638) 638
drug therapy (634) 634
neurosciences (624) 624
vitamin e (616) 616
expression (610) 610
vitamin-d (605) 605
mortality (597) 597
internal medicine (596) 596
research article (595) 595
stroke - prevention & control (590) 590
rodents (589) 589
nutrition & dietetics (586) 586
antioxidants - pharmacology (571) 571
atrial fibrillation - complications (559) 559
bleeding (558) 558
vitamin e - pharmacology (557) 557
studies (556) 556
cells, cultured (551) 551
gene expression (544) 544
apoptosis (541) 541
inflammation (539) 539
review (536) 536
vitamin b (532) 532
diet (531) 531
enzymes (524) 524
thrombosis (524) 524
dietary supplements (523) 523
multidisciplinary sciences (523) 523
pregnancy (511) 511
nutrition (504) 504
medical research (495) 495
warfarin - therapeutic use (491) 491
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (109) 109
UTL at Downsview - May be requested (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Gerstein Science - Reference (4) 4
UofT at Mississauga - Stacks (4) 4
Chemistry (A D Allen) - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Online Resources - Online (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - General (2) 2
UofT at Scarborough - Stacks (2) 2
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Providence Healthcare - Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
Victoria University E.J. Pratt - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15110) 15110
French (607) 607
German (347) 347
Spanish (113) 113
Russian (94) 94
Japanese (53) 53
Italian (39) 39
Polish (26) 26
Portuguese (26) 26
Danish (24) 24
Hungarian (20) 20
Dutch (14) 14
Korean (12) 12
Chinese (6) 6
Romanian (6) 6
Norwegian (5) 5
Swedish (5) 5
Czech (4) 4
Turkish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Finnish (2) 2
Arabic (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 09/2013, Volume 128, Issue 11, pp. 1234 - 1243
BACKGROUND—Patients experiencing major bleeding while taking vitamin K antagonists require rapid vitamin K antagonist reversal. We performed a prospective... 
CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT REVERSAL | CLINICAL-TRIAL | RECOMBINANT FACTOR-VIII | vitamin K antagonist | prothrombin complex concentrates | PREVIOUSLY UNTREATED PATIENTS | INTRACRANIAL HEMORRHAGE | THERAPY | WARFARIN | TRANSFUSION | HEMOPHILIA-A | anticoagulants | PERIPHERAL VASCULAR DISEASE | plasma | FRESH-FROZEN PLASMA | hemorrhage | Single-Blind Method | Plasma | Prospective Studies | Thromboembolism - chemically induced | Factor IX - therapeutic use | Humans | Middle Aged | Male | Factor IX - adverse effects | Hemorrhage - prevention & control | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Aged, 80 and over | Adult | Factor X - therapeutic use | Female | Factor X - adverse effects | Factor VII - adverse effects | Factor VII - therapeutic use | Emergencies | Anticoagulants - therapeutic use | Treatment Outcome | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Prothrombin - adverse effects | Hemostatics - adverse effects | International Normalized Ratio | Hemorrhage - drug therapy | Blood Coagulation Factors - adverse effects | Anticoagulants - pharmacology | Blood Coagulation Factors - therapeutic use | Aged | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Drug Combinations | Antidotes - therapeutic use | Antagonists (Biochemistry) | Usage | Care and treatment | Blood coagulation factors | Health aspects | Hemorrhage | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2015, Volume 36, Issue 28, pp. 1805 - 1811
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 132, Issue 13, pp. 1252 - 1260
Background-The safety and effectiveness of non-vitamin K antagonist (VKA) oral anticoagulants, dabigatran or rivaroxaban, were compared with VKA in... 
atrial fibrillation | databases, factual | Databases | Factual | anticoagulants | comparative effectiveness research | France | stroke | hemorrhage | pharmacoepidemiology | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTICOAGULATION CONTROL | METAANALYSIS | QUALITY | EFFICACY | SAFETY | PREVENTION | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | PERIPHERAL VASCULAR DISEASE | Dabigatran - adverse effects | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Warfarin - adverse effects | Risk | Dabigatran - therapeutic use | Thrombophilia - etiology | Warfarin - therapeutic use | Young Adult | Vitamin K - antagonists & inhibitors | Rivaroxaban - adverse effects | Thromboembolism - prevention & control | Adult | Rivaroxaban - therapeutic use | Thrombophilia - drug therapy | Databases, Factual | Antithrombins - therapeutic use | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Thromboembolism - etiology | Anticoagulants - adverse effects | Arterial Occlusive Diseases - etiology | Factor Xa Inhibitors - therapeutic use | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Adolescent | Aged | Arterial Occlusive Diseases - prevention & control | Hemorrhage - chemically induced | Antagonists (Biochemistry) | Complications and side effects | Rivaroxaban | Atrial fibrillation | Dosage and administration | Thromboembolism | Drug therapy | Comparative analysis | Hemorrhage | Risk factors | Index Medicus | Abridged Index Medicus | 184 | Original | 185
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 10/2016, Volume 116, Issue 4, pp. 754 - 763
In the RE-LY clinical trial, dabigatran presented a better effectiveness/safety profile when compared to warfarin. However, clinical trials are not very... 
Dabigatran | Vitamin K antagonist | Atrial fibrillation | Real-world | Meta-analysis | POPULATION | SAFETY | RIVAROXABAN | meta-analysis | RISK | MYOCARDIAL ISCHEMIC EVENTS | vitamin K antagonist | INTRACRANIAL HEMORRHAGE | STROKE | real-world | WARFARIN | ORAL ANTICOAGULANTS | dabigatran | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | HEMATOLOGY
Journal Article
BMJ (Online), ISSN 0959-8146, 2018, Volume 360, pp. j5424 - j5424
Journal Article